An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many people taking semaglutide stopped their fatty ...

The drug may treat multiple conditions at once, says Grace Su, president of the American Association for the Study of Liver Diseases. Novo Nordisk, the company that makes Ozempic and Wegovy ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many people taking semaglutide stopped their fatty ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has found. Nearly twice as many people taking semaglutide stopped their fatty ...

Many folks in NC can’t access Ozempic due to limited insurance coverage. But policy changes and falling prices may expand ...

A game-changing medication known for diabetes and weight loss might also hold the key to improving liver health for millions of Americans.

International study looked at 800 patients in 37 countries Patients getting the drug saw less inflammation and fat in their livers Lead researcher says it could help treat liver disease like MASH ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ — 63%, compared with 34% of those taking a placebo, researchers reported ...